Archive for February 6th, 2007

Psychodynamic therapy works for panic disorder

The New York Times today reported on a new study demonstrating that psychoanalytically-informed psychotherapy is effective for panic disorder. In fact, it had a very impressive response rate:

In Rigorous Test, Talk Therapy Works for Panic Disorder
By Benedict Carey

The field of psychoanalysis has struggled with a disabling internal conflict in recent years: whether to subject the therapy to rigorous testing, like the process through which new drugs are approved, or to insist that the insights it provides are self-evident and cannot be put under a microscope.

This internal debate has raged even as analysis, Freud’s open-ended talking cure, has become increasingly marginalized as a practice. But the ground rules may soon change.

Last week, a team of New York analysts published the first scientifically rigorous study of a short-term variation of the therapy for panic disorder, a very common form of anxiety. The study was small, but the therapy proved to be surprisingly effective in a group of severely disabled people.

The paper, which appeared in psychiatry’s flagship journal, The American Journal of Psychiatry, is one of the most significant steps in a small but growing effort to study how this so-called psychodynamic therapy works, and for whom.

The brand of therapy tested relies on core tenets of analysis, like the search for the underlying psychological meaning of symptoms. But unlike traditional psychoanalysis, it focused on relieving symptoms quickly, and was time-limited. Previous studies of similar approaches have shown some promise for other disorders, like depression.

“It is very exciting, because you rarely see this kind of therapy studied at all, and it was very rigorously done,” said Dr. Dianne Chambless, a professor of psychiatry at the University of Pennsylvania who was not involved in the study but is now collaborating with the researchers.

Dr. David H. Barlow, a psychiatrist at Boston University, said in an e-mail message that the study was too small to be conclusive but that “the authors should be congratulated for actually taking the first step in doing the hard work of beginning to evaluate treatments” that are widely used without good supportive evidence.

The researchers tested a pared-down version of analysis tailored specifically for panic attacks, the breathless, paralyzing dread that strikes some 1 percent to 2 percent of people, seemingly out of nowhere. Previous studies had found that other kinds of therapy — including exposure techniques, in which people learn to diffuse their anxieties by facing them one small step at a time — can relieve panic attacks in half to two-thirds of patients, depending on the severity and type of anxiety.

In the new experiment, Dr. Barbara L. Milrod, a psychiatrist at Weill Medical College of Cornell University, led a team of therapists who treated 49 men and women with a variety of anxieties. Some were agoraphobic, unable to ride the subway or visit certain parts of town. Others had symptoms of depression or of personality problems, like a disabling dependency on other people or an avoidance of social situations.

Half of the group received a form of relaxation training, in which they learned how to moderate their arousal by tensing and relaxing specific muscle groups. The other half received psychodynamic therapy, working with their therapist in two weekly sessions to understand the underlying meaning of their symptoms — when the reactions first started and how they might be linked to loss, broken relationships or childhood experiences that unconsciously haunted their current lives.

After 12 weeks, 39 percent of those working with relaxation techniques improved significantly on standard measures of anxiety and reported fewer panic-related problems in their relationships and work. But almost three-quarters of those receiving psychodynamic therapy reported similar benefits.

“This is best response rate I’ve seen in a controlled trial for panic,” Dr. Milrod said. “And the therapy was time-limited. I don’t think anyone would care if psychoanalysis cured panic in six years — snore. We wanted to know that what we were doing worked, that it wasn’t malpractice.”

Researchers from Columbia University, the Mount Sinai School of Medicine and Hunter College were also involved.

Studies of this brand of therapy are important for the thousands of therapists around the world who mix and match analytic techniques with other therapies. One former patient treated with this therapy began to have panic attacks after witnessing a young woman die of an illness, said her doctor, Fredric N. Busch, a Cornell psychiatrist and a co-author of the new study.

The patient, who was not a part of the study, described the death as deeply unfair, and in sessions explored perceptions of unfairness in her work and her life, including her childhood. “Once she was able to understand this pattern, the panic became less frightening, she felt safer and was eventually able to get rid of the symptoms,” Dr. Busch said.

The researchers said that even if this approach was not for everyone, it appeared to be especially beneficial for a particular group. In an analysis of individual patient’s responses, the researchers found that those who also had a personality disorder, like avoidant personality, showed significantly greater improvement than those whose symptoms were related solely to anxiety. Patients with multiple diagnoses are usually more difficult to treat.

“This finding was very surprising and there’s absolutely no precedent for it, as far as I know,” Dr. Milrod said.

See also the paper’s abstract:

OBJECTIVE: The purpose of this study was to determine the efficacy of panic-focused psychodynamic psychotherapy relative to applied relaxation training, a credible psychotherapy comparison condition. Des- pite the widespread clinical use of psychodynamic psychotherapies, randomized controlled clinical trials evaluating such psychotherapies for axis I disorders have lagged. To the authors’ knowledge, this is the first efficacy randomized controlled clinical trial of panic-focused psychodynamic psychotherapy, a manualized psychoanalytical psychotherapy for patients with DSM-IV panic disorder.

METHOD: This was a randomized controlled clinical trial of subjects with primary DSM-IV panic disorder. Participants were recruited over 5 years in the New York City metropolitan area. Subjects were 49 adults ages 18–55 with primary DSM-IV panic disorder. All subjects received assigned treatment, panic-focused psychodynamic psychotherapy or applied relaxation training in twice-weekly sessions for 12 weeks. The Panic Disorder Severity Scale, rated by blinded independent evaluators, was the primary outcome measure.

RESULTS: Subjects in panic-focused psychodynamic psychotherapy had significantly greater reduction in severity of panic symptoms. Furthermore, those receiving panic-focused psychodynamic psychotherapy were significantly more likely to respond at treatment termination (73% versus 39%), using the Multicenter Panic Disorder Study response criteria. The secondary outcome, change in psychosocial functioning, mirrored these results.

CONCLUSIONS: Despite the small cohort size of this trial, it has demonstrated preliminary efficacy of panic-focused psychodynamic psychotherapy for panic disorder.

At last my psychodynamic colleagues are engaging in the difficult work of validating our treatments. These authors deserve much praise for the pioneering effort. Its nice, but not critical, that we also like the results!

Add comment February 6th, 2007

Music: Country Joe McDonald - I Feel Like I’m Fixin’ To Die

Unfortunately, never out of date:

Add comment February 6th, 2007

Schizophrenia associated with physical illness

Jeffrey Kluger, science writer for Time, has a blog piece on new data on the costs in physical illness, of schizophrenia:

More Hardship for Schizophrenics

You’d think that people unlucky enough to suffer from schizophrenia would get a pass on other kinds of health woes. Now however, a new study in the Journal of General Internal Medicine makes it clearer than ever that being afflicted with this most devastating of mental diseases can open you up to a wealth of physical ills as well.

Schizophrenia is thought to afflict anywhere from .5% to 1.5% of the world’s population, depending on who’s doing the counting. While this does not seem like an enormous number, in the U.S. that could mean as many as 4.5 million people. By some estimates, that kind of patient load carries a cost of $65 billion per year in terms of direct medical expenses, lost productivity and other burdens. But the price tag in both dollars and human suffering may actually be much higher.

Physician Caroline Carney Doebbeling of the Indiana University School of Medicine analyzed health insurance claims from a whopping 700,000 adults between 18 and 64 years of age to compare the physical well-being of people with schizophrenia to those without it. The results were sobering. Schizophrenia patients, she found, were significantly likelier than others to be battling one or more of fully 46 chronic conditions, including various kinds of cardiovascular, pulmonary, neurological or endocrine ills. In general, only 29% of schizophrenics were free of such ailments, compared to 54% of controls. What’s more, the onset of the diseases was earlier, with a third of schizophrenics under 40 already diagnosed with three or more physical conditions that placed them under a doctor’s care.

What it means: It’s no surprise that people with chronic mental illnesses have a harder time taking care of their physical health. Dr. Carney Doebbeling had already studied the link between mental woes in general and the incidence of cancer and diabetes, as well as a resistance among female patients to undergo mammograms. It’s the extent and severity of the problems in schizophrenics that is new. With more and more schizophrenia drugs becoming available all the time, the disease is growing increasingly manageable, if not curable. More than ever, this argues for a better-integrated treatment of schizophrenics, with health care providers monitoring their physical health as closely as their mental health. The hard struggle to save a mind should not be wasted by letting the body go.

It should be kept in mind that the mechanism involved here still need to be clarified. For example, we have considerable evidence that schizophrenics smoke at a much higher rate than does the non-schizophrenic population, or even than other “mentally ill” groups. There is some evidence that this fact may have, at least partially, a biochemical basis. In any case, this increased smoking rate undoubtedly is responsible for some of the elevated rate of physical illness. It increases the need for the development of effective strategies of smoking cessation in this population.

I also wonder if there is any evidence on how various treatments impact the physical health of schizophrenics. For example, do more comprehensive psychosocial approaches [with or without a pharmacological component] lead to better physical outcomes than do the prevalent largely pharmacological ones? While speculative, evidence here could counter the presumed “cost-effectiveness” of the dominant pharmacological paradigm.

Add comment February 6th, 2007


Pages

Calendar

February 2007
M T W T F S S
« Jan   Mar »
 1234
567891011
12131415161718
19202122232425
262728  

Posts by Month

Posts by Category